Table 6.
Study | HR estimation | Co-factors | Analysis results |
---|---|---|---|
Osawa [19] | HR, 95 % CI | Histology, no. of positive LNs, adjuvant chemotherapy | Significant |
Guzzo [22] | HR, 95 % CI | Age, sex, diversion type, pT stage, adjuvant chemotherapy | Not significant |
Stephenson [23] | HR, 95 % CI | pT stage, aggregate LN metastasis diameter, lymphovascular invasion, margin status, extracapsular extension | Not significant |
Morgan [26] | HR, 95 % CI | Age, Charlson comorbidity index, pT stage, tumor grade, no. of LNs removed, adjuvant chemotherapy, diversion type, year of surgery, surgeon volume, transfusion | Significant |
Mmeje [29] | P value, event no. (univariate) | - | Not significant |
HR: hazard ratio, CI: confidence interval, LN: lymph node